Neurocrine Biosciences

Our Company

Neurocrine Biosciences of San Diego discovers and develops innovative and life-changing pharmaceuticals, in diseases with high unmet medical needs, through its novel R&D platform, focused on neurological and endocrine based diseases and disorders.

In the News
1/20/2015 Neurocrine Biosciences Announces Oral Presentation of NBI-77860 Clinical Trial Data in Classic Congenital Adrenal Hyperplasia at ENDO 2015
1/16/2015 Neurocrine Biosciences Announces Granting of Orphan Drug Status for NBI-77860 in Congenital Adrenal Hyperplasia view all press releases

Webcast Webcast

Neurocrine frequently conducts webcasts and conference calls to provide presentations and company updates and progress on research and development activiites.

 view current webcasts 

New Data Our Corporation Presentation

This presentation provides an overview of our company pipeline, program process, and financial highlights.

/common/images/orangearrow.gif view the presentation

Stock Quote
Price Quote 33.54
Change -0.01
(20 minutes delayed)
4:00 pm